Serving clients with the most advanced and up-to-date expertise is core to the achievement of our vision. Our team publishes regularly on matters concerning vaccines, vaccine-preventable and neglected tropical diseases.

  • Mantel C, Khamassi S, Baradei K, Nasri H, Mohsni E, Duclos P. “Improved injection safety after targeted interventions in the Syrian Arab Republic.” Trop Med Int Health. 2007 Mar; 12(3):422-30.
  • Mantel C, Yakubu A, Vandelaer J. “Status of Neonatal Tetanus Elimination in the United Republic of Tanzania – Results from a Lot Quality Assurance- Cluster Survey.” Weekly Epidemiological Record. 2009 17th July; 29 (84):290-9.
  • Mantel C, Wang SA. “The privilege and responsibility of having choices: decision-making for new vaccines in developing countries.” Health Policy Plan. 2012 May;27 Suppl 2:ii1-4
  • Cherian T, Wang S, Mantel C. “Rotavirus vaccines in developing countries: the potential impact, implementation challenges, and remaining questions.” Vaccine 2012 Apr27; 30 Suppl 1:A3-6.
  • Hyde TB, Dentz H, Wang SA, Burchett HE, Mounier-Jack S, Mantel C. “The impact of new vaccine introduction on immunization and health systems: a review of the published literature.” Vaccine 2012 Oct 5; 30(45):6347-58.
  • Wang SA, Mantel C, Gacic-Dobo M, Dumolard L, Cherian T, Flannery B, Loo J, Verani J, Whitney CG. “Progress of introduction of pneumococcal conjugate vaccine – worldwide, 2000-2012”. MMWR 2013 April 26; 62(16): 308-11.
  • Wallace AS, Mantel C, Mayers G, Mansoor O, Gindler JS, Hyde TB. “Experiences with provider and parental attitudes and practices regarding the administration of multiple injections during infant vaccination visits: Lessons for vaccine introduction”. Vaccine 2014 Sep 15; 32(41):5301-10.
  • Loharikar A, Dumolard L, Chu S, Hyde T, Goodman T, Mantel C. “Status of New Vaccine Introduction — Worldwide, September 2016” MMWR 2016, Oct 21; 65(41): 1136–40.
  • Lyimo D, Kamugisha C, Yohana E, Eshetu M, Wallace A, Ward K, Mantel C, Hennessey K. “Improving the efficiency and standards of a National Immunization Program Review: lessons learnt from United Republic of Tanzania.” Pan African Med J 2017; 28:209.
  • Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, et al.  “Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.” Vaccine 2017;35(25):3303-8.
  • Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, et al. “Case-control vaccine effectiveness studies: Data collection, analysis and reporting results.” Vaccine 2017;35(25):3295-3302.
  • Mahomed N, Fancourt N, de Campo J, de Campo M, Akano A, Cherian T et al. “Preliminary report from the World Health Organisation Chest Radiography in Epidemiological Studies project.” Pediatr Radiol 2017;47(11):1399-1404.
  • Dolan SB, Patel M, Hampton LM, Burnett E, Ehlman DC, Garon J, Cloessner E, Chmielewski E,  Hyde TB, Mantel C, Wallace A. “Administering Multiple Injectable Vaccines – Summary of findings from the accelerated introduction of inactivated polio vaccine globally.” JID 2017 Suppl.
  • Cernuschi T., Malvolti S., Nickels E., Friede M. “Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance.” Vaccine. 2018 Jan 25;36(4):498-506.
  • Roos N, Lambach P, Mantel C, Mason E, Munoz FM, Giles M, Moran A, Hombach J, Diaz T. “Maternal Immunization and Antenatal Care Situation Analysis (MIACSA) study protocol: a multiregional, cross-sectional analysis of maternal immunization delivery strategies to reduce maternal and neonatal morbidity and mortality.” BMJ Open 2019; 9 (6).
  • Malhame M, Baker E, Gandhi G, Jones A, Kalapaxis P, Iqbal R, Momeni Y, Nguyen A.  “Shaping markets to benefit global health – A 15-year history and lessons learned from the pentavalent vaccine market.” Vaccine 2019 August, 100033. 
  • Aliabadi N, Antoni S. Mwenda J, Weldegebriel G, Biey J, Cheikh D, Cherian T, et al. “Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008–16: findings from the Global Rotavirus Surveillance Network.” Lancet Global Health 2019; 7.
  • Cherian T, Morales KF, Mantel C, Lambach P, “Independent Expert Advisory Group for Health Worker Influenza V. Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16-17, Berlin, Germany.” Vaccine, 2019, 37(43): 6255-61.
  • La Vincente SF, MollendorfC, Ulziibayar M, Satzke C, Dashtseren L, Fox KK, Dunne E, Nguyen CD, De Campo J, De Campo M, Thomson H, Surenkhand G, Demberelsuren S, Bujinlkham S, Anh Ha Do L, Narangerel D, Cherian T, Mungun T, Mulholland EK. “Evaluation of a phased pneumococcal conjugate vaccine introduction in Mongolia using enhanced pneumonia surveillance and community carriage surveys: a protocol for a prospective observational study.” BMC Public Health. 2019;19(1):333.
  • Cernuschi T, Gilchrist S, Mariat S, Malhame M, Widmyer G, Hajizada H.  “Price Transparency is a Step Toward Sustainable Access in Midle-Income Countries”, BMG 2019 (In Press).
  • Clarke K, MacNeil A, Hadler S, Scott C, Tiwari T, Cherian T. “Global epidemiology of diphtheria in the 21st century.” Emerging Infectious Diseases 2019  Emerging Infectious Diseases, Vol. 25, No. 10, October 2019.

© MMGH Consulting GmbH, last update: September 2019